Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | +3.49% | -5.84% | -62.12% |
Jul. 01 | ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Microcap Growth Index | CI |
Jul. 01 | ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell Microcap Value Index | CI |
Business Summary
Number of employees: 74
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 15-03-31 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 20-03-31 |
Peter García
DFI | Director of Finance/CFO | 62 | 19-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-10-31 | |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 16-05-31 |
Michael Chang
COO | Chief Operating Officer | - | 15-02-28 |
Shelly Pinto
AUD | Comptroller/Controller/Auditor | 48 | 21-05-02 |
Hong I. Wan
PRN | Corporate Officer/Principal | - | 15-03-31 |
Hank Stern
PRN | Corporate Officer/Principal | - | 14-12-31 |
Chris Byrd
LAW | General Counsel | - | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 22-11-27 |
Corey Goodman
CHM | Chairman | 72 | 15-02-28 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 20-03-31 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 20-03-31 |
Jaume Pons
FOU | Founder | 58 | 15-03-31 |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 16-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,100,107 | 41,331,399 ( 79.33 %) | 0 | 79.33 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.12% | 294M | |
+18.43% | 124B | |
+19.81% | 114B | |
-23.74% | 19.42B | |
-18.45% | 16.2B | |
-19.97% | 15.31B | |
-49.33% | 14.19B | |
+57.08% | 14.32B | |
+7.95% | 14.31B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- ALXO Stock
- Company ALX Oncology Holdings Inc.